Modernizing Pharmaceutical Manufacturing

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2002, Volume 26, Issue 2

FDA's Center for Drug Evaluation and Research is driving efforts toward creating initiatives to streamline regulatory processes, speed up drug production, and reduce costs.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-02-02-2002
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients
Navigating an Uncertain Regulatory Environment for mRNA-based Products
INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities